Domov › Rak (vse vrste) › Washington › Seattle
Klinične študije za Rak (vse vrste) v Seattle, WA
49 študij za Rak (vse vrste) išče udeležence na lokacijah v Seattle in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2/3
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
Registry Study for Radiation Therapy Outcomes
Vključevanje udeležencevOpazovalna študija
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Vključevanje udeležencevOpazovalna študija
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Vključevanje udeležencevFaza 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Vključevanje udeležencevFaza 1
- Swedish Cancer Institute, Seattle
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Vključevanje udeležencev
- Seattle Children's Hospital, Seattle
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Vključevanje udeležencevFaza 3
- Fred Hutchinson Cancer Center ( Site 0106), Seattle
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Vključevanje udeležencevFaza 2
- Swedish Cancer Institute, Seattle
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Vključevanje udeležencevFaza 2/3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
Vključevanje udeležencevOpazovalna študija
- Fred Hutchinson, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Vključevanje udeležencevFaza 2
- Seattle Neuropsychiatric Treatment Center, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Vključevanje udeležencevFaza 1
- Investigational Site Number: 400, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- Fred Hutchinson Cancer Center, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Vključevanje udeležencevOpazovalna študija
- University of Washington, Seattle
Prostate Active Surveillance Study
Vključevanje udeležencevOpazovalna študija
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Seattle Children's Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Vključevanje udeležencevFaza 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- Fred Hutchinson Cancer Center, Seattle
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Vključevanje udeležencevFaza 2
- Seattle Children's Hospital Research Foundation, Seattle
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Vključevanje udeležencevFaza 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- in še 4
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Vključevanje udeležencevFaza 2
- Seattle Children's Hospital, Seattle
Resilience Mobile App for Teens and Young Adults With Cancer
Vključevanje udeležencev
- Seattle Children's Hospital, Seattle
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Vključevanje udeležencevFaza 1
- Fred Hutchinson Cancer Center. /ID# 267940, Seattle
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Vključevanje udeležencevFaza 1
- GSK Investigational Site, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Fred Hutchinson Cancer Center, Seattle
Childhood Cancer Survivor Study
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Seattle Children's Hospital, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Vključevanje udeležencev
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2/3
- University of Washington Medical Center /ID# 275866, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- Fred Hutchinson Cancer Center, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Vključevanje udeležencevFaza 1/2
- University of Washington Medical Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- Fred Hutchinson Cancer Centre, Seattle
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Vključevanje udeležencevFaza 2
- University of Washington, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Vključevanje udeležencevFaza 1
- Fred Hutchinson Cancer Center, Seattle
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Vključevanje udeležencevFaza 2
- Seattle Children's Hospital, Seattle
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Vključevanje udeležencevOpazovalna študija
- Seattle Children's Hospital, Seattle
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Vključevanje udeležencevFaza 2
- Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Vključevanje udeležencevFaza 1
- Fred Hutch Cancer Center, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Vključevanje udeležencevOpazovalna študija
- The Swedish Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
Vključevanje udeležencevFaza 1
- Fred Hutchinson Cancer Center, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Vključevanje udeležencevOpazovalna študija
- Swedish Cancer Institute, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Vključevanje udeležencevOpazovalna študija
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Crowd Sourcing Platform for Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- All4Cure, Seattle
AIMS Cancer Outcomes Study
Vključevanje udeležencevOpazovalna študija
- AIMS Institute, Seattle
Študije za Rak (vse vrste) v drugih mestih
- Houston, TX121 študij
- New York City, NY110 študij
- Boston, MA86 študij
- Los Angeles, CA73 študij
- Nashville, TN65 študij
- Philadelphia, PA59 študij
- Durham, NC58 študij
- Washington, DC58 študij
- Chicago, IL51 študij
- Atlanta, GA49 študij
- Arlington, VA48 študij
- St. Louis, MO46 študij
Druge študije v Seattle
- Nemalicelični pljučni rak53 študij
- Rak prostate42 študij
- Akutna mieločna levkemija40 študij
- Rak dojke39 študij
- Metastatski rak39 študij
- Kolorektalni rak34 študij
- Rak pljuč33 študij
- Rak jajčnikov30 študij
- Množni mielom22 študij
- Mielodisplastični sindromi21 študij
- Akutna limfoblastna levkemija21 študij
- Rak mehurja21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.